Claudio Villota Arcos | Skin Aging | Research Excellence Award

Posted on by Skincare

Dr. Claudio Villota Arcos | Skin Aging | Research Excellence Award

Investigador | Universidad Bernardo O'Higgins | Chile 

Dr. Claudio Villota Arcos is a researcher specializing in cellular and molecular biology, with a strong interdisciplinary focus on cancer biology, mitochondrial genetics, virology, and nutrition-related molecular mechanisms. His research centers on the role of mitochondrial non-coding RNAs in cancer initiation, progression, and therapeutic targeting, alongside emerging interests in viral oncogenesis, metabolic regulation, and inflammation-linked diseases. Dr. Villota Arcos serves as an academic researcher at the School of Nutrition and Dietetics, Universidad Bernardo O’Higgins, where he integrates molecular biology with translational health research. His key contributions include pioneering discoveries on antisense mitochondrial non-coding RNAs as selective vulnerabilities in cancer cells, advancing novel molecular targets for cancer therapy, and influencing diagnostic and therapeutic research strategies. His impact vision emphasizes translating fundamental mitochondrial biology into clinically relevant innovations, strengthening precision oncology approaches, and bridging molecular science with public health and nutritional interventions for global disease prevention.

Citation Metrics (Scopus)

700

400

50

0

Citations
662

Documents
26

h-index
12

🟦 Citations
🟥 Documents
🟩 h-index


View Google Scholar
 View Scopus profile View ORCID profile

Featured Publications


Expression of a family of noncoding mitochondrial RNAs

– Proceedings of the National Academy of Sciences,, 2009

Down-regulation of antisense mitochondrial non-coding

–. Journal of Biological Chemistry, 2014

Reinhard Heinz Hans Neubert | Dermatopharmacy | Distinguished Scientist Award

Posted on by Skincare

Prof. Reinhard Heinz Hans Neubert | Dermatopharmacy | Distinguished Scientist Award

Vice-Chairman  | Matin Luther University | Germany

Prof. Dr.Reinhard Heinz Hans Neubert is a leading researcher specializing in dermal drug delivery and dermatopharmaceutical sciences, currently affiliated with the Institute of Applied Dermatopharmacy (IADP), Martin Luther University Halle-Wittenberg. His research focuses on dermal and transdermal drug delivery systems, nanostructure and organization of stratum corneum lipids, ceramide chemistry, colloidal carrier systems, phytopharmaceuticals, and the application of affinity capillary electrophoresis to optimize topical formulations. With extensive academic and translational experience, he has led large-scale collaborative research initiatives and advised numerous postgraduate researchers while also contributing to industry-oriented innovation through consultancy and technology transfer. His key contributions include pioneering insights into skin barrier lipid organization, advancement of analytical methods for skin penetration studies, and the development of innovative dermal delivery platforms supported by multiple patents. Impact Vision: Prof. Neubert’s work strengthens the scientific foundation of skin barrier research and accelerates the translation of dermatological innovations into effective, safe, and globally relevant therapeutic and cosmetic solutions.

Citation Metrics (Scopus)

14000

1000

600

500

0

Citations
13,603

Documents
474

h-index
56

🟦 Citations
🟥 Documents
🟩 h-index


View Scopus Profile
 View ORCID profile

Featured Publications


Potentials of new nanocarriers for dermal and transdermal drug delivery

–European Journal of Pharmaceutics and Biopharmaceutics, , 2011

Ceramides and barrier function of the skin

– Skin Pharmacology and Physiology, 2015

Affinity capillary electrophoresis as a tool for optimizing topical drug formulations

– Journal of Pharmaceutical and Biomedical Analysis,2019

Panagiotis Halvatsiotis | Skin Health | Research Excellence Award 

Posted on by Skincare

Prof. Panagiotis Halvatsiotis | Skin Health | Research Excellence Award 

Researcher | University of Athens | Greece

Panagiotis Halvatsiotis is an Assistant Professor of Medicine with specialization in endocrinology and metabolic research, focusing on diabetes, obesity, insulin resistance, and metabolic regulation across clinical and molecular contexts. His research explores skeletal muscle metabolism, protein synthesis, adipokine signaling, and the metabolic impact of nutritional and pharmacological interventions, alongside emerging interests in population-based metabolic risk and COVID-19–related metabolic outcomes. He holds key academic and clinical research roles within university medical settings and has collaborated extensively in multidisciplinary, international research teams. Dr. Halvatsiotis has made significant contributions through high-impact studies elucidating insulin action, amino acid kinetics, and metabolic dysregulation in type 2 diabetes, as well as influential systematic reviews informing dietary and public health policy. His work has generated widely cited evidence shaping clinical practice guidelines. His impact vision centers on translating metabolic research into scalable interventions that improve chronic disease management, inform evidence-based nutrition strategies, and advance global metabolic health innovation.

Citation Metrics (Google Scholar)

1500

1000

600

0

Citations
1455

Documents
17

h-index
28

🟦 Citations
🟥 Documents
🟩 h-index


View Google Scholar

Featured Publications

Meheli Ghosh | Dermatology | Research Excellence Award

Posted on by Skincare

Meheli Ghosh | Dermatology | Research Excellence Award

PHD | Mercer University | United States

Meheli Ghosh is a pharmaceutical sciences researcher specializing in advanced drug delivery systems and dermatological/transdermal formulation development. Her research focuses on topical and transdermal drug delivery, microneedle-based systems, nanoparticulate and microparticulate carriers, foam and gel formulations, and quality-by-design approaches for skin-targeted therapies, with emerging interests in regulatory-relevant bioequivalence and late-stage product development. She has gained significant research experience through collaborative projects with the U.S. Food and Drug Administration, NIH-funded programs, and industry-aligned research at Merck Group, contributing to formulation design, process optimization, IVRT/IVPT studies, and regulatory documentation. Her key contributions include the development of novel drug-loaded microneedles using vacuum compression molding, innovative nanoparticle- and emulsome-based systems for chemical injury mitigation, and advanced topical platforms addressing unmet dermatological needs. Impact Vision: Her work bridges academic research and regulatory science, accelerating the translation of safe, effective, and scalable dermatological therapies that advance global skin health and pharmaceutical innovation.

 

Citation Metrics (Google Scholar)

100

80

60

20

0

Citations
94

i10-index
4

h-index
4

🟦 Citations
🟥 i10-index
🟩 h-index


View Google Scholar

Featured Publications